RE:RE:RE:Roche for the buyoutAt the very least and for patients' sake, Pancan should be able to move this along quicker with its ongoing sites, FDA relationship, public support and lobbying etc than a corporate entity would. Roche certainly doesn't need a charity to run a trial for them but they will have a pretty clear investment case for their shareholders with the go-no-go decision in 2025 for a full PIII regardless of premium to be paid or ONC's long history. No one knows if it'll get that far without an accelerated approval, buyout, partnership or what have you, but that's the nature of a speculative play. I believe Roche won't let this get much further without getting involved somehow and as a shareholder I've made my wager, but you're right, until that press release comes out.......